- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/27 - Colony stimulating factors
Patent holdings for IPC class C12N 15/27
Total number of patents in this class: 52
10-year publication summary
0
|
1
|
0
|
4
|
1
|
3
|
2
|
1
|
2
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Provincial Health Services Authority | 185 |
3 |
UVic Industry Partnerships Inc. | 103 |
3 |
Hanmi Science Co., Ltd. | 135 |
2 |
Institute for Research in Biomedicine (IRB) | 40 |
2 |
Regeneron Pharmaceuticals, Inc. | 4296 |
2 |
Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2037 |
2 |
Yale University | 2399 |
2 |
Zymeworks Inc. | 257 |
2 |
Merck Sharp & Dohme Corp. | 2191 |
1 |
Amgen Inc. | 4081 |
1 |
Academia Sinica | 943 |
1 |
Ambrx, Inc. | 183 |
1 |
BioNTech RNA Pharmaceuticals GmbH | 73 |
1 |
Central Institute for Experimental Animals | 25 |
1 |
Children's Healthcare of Atlanta, Inc. | 245 |
1 |
CHS Pharma, Inc. | 9 |
1 |
Eberhard Karls Universität Tübingen Medizinische Fakultät | 74 |
1 |
Elanco US Inc. | 727 |
1 |
Emory University | 1621 |
1 |
Gradalis, Inc. | 50 |
1 |
Other owners | 22 |